About
Drugs
Take action
Fluvoxamine
FAQ
Donate

Our Team

The COVID-19 Early Treatment Fund team is comprised of experts from a wide range of fields including medicine, technology, philanthropy, and business. Together, we have quickly become the world's leading fund focused on early treatments for COVID-19 that leverage repurposed drugs. We believe that this is the shortest path to reduce hospitalizations and save lives now.

Steve Kirsch
Founder and CEO
Hilary Grant-Valdez
Operations Manager
Dr. Lisa Danzig
Medical Advisor
Julie Rajagopal
Strategic Advisor
Tom Brunner
Operations Advisor
Gary Dicovitsky
Development Advisor
Donate to the
COVID-19 Early Treatment Fund today
Donate
Find a Trial
Apply for Funding

The COVID-19 Early Treatment Fund (CETF) is administered by Rockefeller Philanthropy Advisors, a 501(c)(3) public charity (EIN: 13-3615533). All donations to CETF are tax deductible and go exclusively towards funding outpatient trials.